MRM

MEDIROM Healthcare Technologies

MRM

Market cap $15M

Overview Fund Activity

1.90 USD

+0.05

2.7%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

1.85

-0.05

2.63%

1 day

2.7%

5 days

19.5%

1 month

-13.24%

3 months

15.15%

6 months

201.59%

Year to date

88.12%

1 year

-53.43%

5 years

-87.43%

10 years

-87.43%

About: MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Employees: 1,051

Consumer Discretionary Personal Services

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

100% more funds holding

Funds holding: 3 [Q1] → 6 (+3) [Q2]

56% more capital invested

Capital invested by funds: $66K [Q1] → $103K (+$36.9K) [Q2]

1.36% less ownership

Funds ownership: 2.28% [Q1] → 0.92% (-1.36%) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

See Fund Rankings

Financial journalist opinion

Medirom's “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device

TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”, “we” or “us”) announces that its “REMONY for Driver” remote health management system, developed by its subsidiary MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has been selected by Japan's Ministry of Land, Infrastructure, Transport and Tourism (“MLIT”) under its Accident Prevention Support and Promotion Program as a certified device for preventing fatigue-related driving.

Medirom's “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device

MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"

TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM) (the “Company”, “we” or “us”), which operates a diversified healthcare business, announced its participation in “World,” a “proof of human” protocol co-founded by Sam Altman and Alex Blania. The purpose of this project is to build a new digital infrastructure that will enable "proof of humanness" in the age of AI.

MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"

MEDIROM Joins the World Network, Embracing Next-Generation Proof of Human Concept Led by ChatGPT Creator Sam Altman

Creating new social infrastructure in collaboration with Hakuhodo To promote the spread of World ID in Japan, Verification Device“Orb”will be installed in 100 Re.Ra.Ku relaxation salons.

MEDIROM Joins the World Network, Embracing Next-Generation Proof of Human Concept Led by ChatGPT Creator Sam Altman

MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements

MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements. The Company's ADSs had been $1.00 per share or greater.

MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements

Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!

TOKYO, May 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM," "we,” “us” or “our”), a holistic healthcare company based in Japan, announces that its subsidiary, MEDIROM MOTHER Labs, Inc., has surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals in its specific health guidance service utilizing the healthcare app "Lav."

Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!

MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET

TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See “Convenience Translations to US Dollars” below for more information.)

MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company's financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time.

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing

TOKYO, March 17, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that it has obtained a new unsecured short-term bank loan in the amount of JPY350 million (approximately $2.4 million*). The Company has used JPY200 million of the loan funds for repayment of indebtedness of MEDIROM Mother Labs Inc., a subsidiary of the Company which is also a guarantor of the new loan, and the Company intends to use the remainder of the loan funds for general working capital, including Mother Bracelet development. The loan bears interest at a rate of 1.875% per year.

MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. (“Mother Labs”), a subsidiary of the Company, has made a second investment in Mother Labs' Series A financing at a pre-money valuation of JPY9 billion (as of March 13, 2025, approximately US$60 million). This new investment follows Mr. Hayami's initial investment in the Series A financing in December 2024. Mr. Hayami is a committed senior executive of Mother Labs and shares MEDIROM's corporate philosophy and vision as well as commitment to future growth potential.

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)

Total Customers Served: 80,764 – Sales Per Customer: JPY 7,384 – Customer Repeat Ratio: 77.6% Total Customers Served: 80,764 – Sales Per Customer: JPY 7,384 – Customer Repeat Ratio: 77.6%

MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)

See News Rankings

Charts implemented using Lightweight Charts™